SERDS: Relevance and Role in Current & Future Treatments for HR+, HER2- MBC

410 views
July 24, 2024

In this video, Dr. Komal Jhaveri shares her expertise on SERDs for the treatment of HR+, HER2- MBC, including the evolving role of novel oral SERDs.

To access additional videos and download free resources, click here.

VV-OTHR-US-DEL-3129 © 2024 Lilly USA, LLC. All Rights Reserved.

Comments are disabled for this content.